Indobufen
吲哚布芬
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameIndobufen
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesPfizer Inc
Active Indications
Inactive Indications